Comparing different metabolic indexes to predict type 2 diabetes mellitus in a five years follow-up cohort: The Baependi Heart Study
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | OLIVEIRA, Camila Maciel de | |
dc.contributor.author | PAVANI, Jessica Leticia | |
dc.contributor.author | LIU, Chunyu | |
dc.contributor.author | BALCELLS, Mercedes | |
dc.contributor.author | CAPASSO, Robson | |
dc.contributor.author | ALVIM, Rafael de Oliveira | |
dc.contributor.author | MOURAO-JUNIOR, Carlos Alberto | |
dc.contributor.author | KRIEGER, Jose Eduardo | |
dc.contributor.author | PEREIRA, Alexandre Costa | |
dc.date.accessioned | 2022-10-26T14:20:06Z | |
dc.date.available | 2022-10-26T14:20:06Z | |
dc.date.issued | 2022 | |
dc.description.abstract | This study evaluates the association of anthropometric indexes and the incidence of type 2 diabetes mellitus (T2DM) after a 5-year follow-up. This analysis included 1091 middle-aged participants (57% women, mean age 47 +/- 15 years) who were free of T2DM at baseline and attended two health examinations cycles [cycle 1 (2005-2006) and cycle 2 (2010-2013)]. As expected, the participants who developed T2DM after five years (3.8%) had the worst metabolic profile with higher hypertension, dyslipidemia, and obesity rates. Besides, using mixed-effects logistic regression and adjustment for sex, age, and glucose, we found that one unit increase in body adiposity index (BAI) was associated with an 8% increase in their risk of developing T2DM (odds ratio [OR] = 1.08 [95% CI, 1.02-1.14]) and visceral adiposity index (VAI) was associated with a risk increase of 11% (OR = 1.11 [95% CI, 1.00-1.22]). Moreover, a one-unit increase in the triglycerides-glucose index (TyG) was associated with more than four times the risk of developing T2DM (OR = 4.27 [95% CI, 1.01-17.97]). The interquartile range odds ratio for the continuous predictors showed that TyG had the best discriminating performance. However, when any of them were additionally adjusted for waist circumference (WC) or even body mass index (BMI), all adiposity indexes lost the effect in predicting T2DM. In conclusion, TyG had the most substantial predictive power among all three indexes. However, neither BAI, VAI, nor TyG were superior to WC or BMI for predicting the risk of developing T2DM in a middle-aged normoglycemic sample in this rural Brazilian population. | eng |
dc.description.index | MEDLINE | eng |
dc.description.sponsorship | NIH/NHLBI [R01HL141881] | |
dc.description.sponsorship | Sao Paulo Research Foundation (FAPESP) | |
dc.description.sponsorship | Hospital Samaritano Society through the Ministry of Health to Support Program Institutional Development of the Unified Health System (SUSPROADI) [25000.180.664/2011-35] | |
dc.description.sponsorship | Fundacion Empreses IQS | |
dc.description.sponsorship | Global CoCreation Lab, Inc (Miami, FL) | |
dc.description.sponsorship | Spain Minister of Economy [SAF2017-84773-C2-1-R] | |
dc.identifier.citation | PLOS ONE, v.17, n.6, article ID e0267723, 9p, 2022 | |
dc.identifier.doi | 10.1371/journal.pone.0267723 | |
dc.identifier.issn | 1932-6203 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/49160 | |
dc.language.iso | eng | |
dc.publisher | PUBLIC LIBRARY SCIENCE | eng |
dc.relation.ispartof | Plos One | |
dc.rights | openAccess | eng |
dc.rights.holder | Copyright PUBLIC LIBRARY SCIENCE | eng |
dc.subject.other | visceral adiposity index | eng |
dc.subject.other | association | eng |
dc.subject.wos | Multidisciplinary Sciences | eng |
dc.title | Comparing different metabolic indexes to predict type 2 diabetes mellitus in a five years follow-up cohort: The Baependi Heart Study | eng |
dc.type | article | eng |
dc.type.category | original article | eng |
dc.type.version | publishedVersion | eng |
dspace.entity.type | Publication | |
hcfmusp.affiliation.country | Estados Unidos | |
hcfmusp.affiliation.country | Chile | |
hcfmusp.affiliation.country | Espanha | |
hcfmusp.affiliation.countryiso | cl | |
hcfmusp.affiliation.countryiso | us | |
hcfmusp.affiliation.countryiso | es | |
hcfmusp.author.external | OLIVEIRA, Camila Maciel de:Stanford Univ, Sch Med, Stanford, CA 94305 USA; Univ Sao Paulo Med Sch, Heart Inst InCor, Lab Genet & Mol Cardiol, Sao Paulo, Brazil; Univ Fed Parana, Dept Integrat Med, Curitiba, Parana, Brazil | |
hcfmusp.author.external | PAVANI, Jessica Leticia:Pontificia Univ Catolica Chile, Dept Stat, Santiago, Chile | |
hcfmusp.author.external | LIU, Chunyu:Framingham Heart Dis Epidemiol Study, Framingham, MA USA; Boston Univ, Dept Biostat, Boston, MA 02215 USA | |
hcfmusp.author.external | BALCELLS, Mercedes:MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; Ramon Llull Univ, Inst Quim Sarria, Bioengn Dept, Barcelona, Spain | |
hcfmusp.author.external | CAPASSO, Robson:Stanford Univ, Sch Med, Stanford, CA 94305 USA | |
hcfmusp.author.external | ALVIM, Rafael de Oliveira:Univ Sao Paulo Med Sch, Heart Inst InCor, Lab Genet & Mol Cardiol, Sao Paulo, Brazil; Univ Fed Amazonas, Dept Physiol Sci, Manaus, Amazonas, Brazil | |
hcfmusp.author.external | MOURAO-JUNIOR, Carlos Alberto:Univ Fed Juiz de Fora, Dept Physiol, Juiz De Fora, Brazil | |
hcfmusp.citation.scopus | 1 | |
hcfmusp.contributor.author-fmusphc | JOSE EDUARDO KRIEGER | |
hcfmusp.contributor.author-fmusphc | ALEXANDRE DA COSTA PEREIRA | |
hcfmusp.description.articlenumber | e0267723 | |
hcfmusp.description.issue | 6 | |
hcfmusp.description.volume | 17 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.pubmed | 35657786 | |
hcfmusp.origem.scopus | 2-s2.0-85131702219 | |
hcfmusp.origem.wos | WOS:000843619700089 | |
hcfmusp.publisher.city | SAN FRANCISCO | eng |
hcfmusp.publisher.country | USA | eng |
hcfmusp.relation.reference | Alvim RO., 2014, PLOSONE | eng |
hcfmusp.relation.reference | Amato MC, 2010, DIABETES CARE, V33, P920, DOI 10.2337/dc09-1825 | eng |
hcfmusp.relation.reference | Bergman RN, 2011, OBESITY, V19, P1083, DOI 10.1038/oby.2011.38 | eng |
hcfmusp.relation.reference | Chamroonkiadtikun P, 2020, PRIM CARE DIABETES, V14, P161, DOI 10.1016/j.pcd.2019.08.004 | eng |
hcfmusp.relation.reference | de Oliveira CM, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-32 | eng |
hcfmusp.relation.reference | de Oliveira CM, 2020, PREV MED REP, V20, DOI 10.1016/j.pmedr.2020.101172 | eng |
hcfmusp.relation.reference | de Oliveira CM, 2019, DIABETOL METAB SYNDR, V11, DOI 10.1186/s13098-019-0467-1 | eng |
hcfmusp.relation.reference | diabetesatlas.org, IDF DIABETES ATLAS | eng |
hcfmusp.relation.reference | Egan KJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011598 | eng |
hcfmusp.relation.reference | Flor Luisa Sorio, 2017, Rev. bras. epidemiol., V20, P16, DOI 10.1590/1980-5497201700010002 | eng |
hcfmusp.relation.reference | Freitas Isabel Cristina Martins de, 2016, Rev. bras. epidemiol., V19, P433, DOI 10.1590/1980-5497201600020018 | eng |
hcfmusp.relation.reference | Guerrero-Romero F, 2010, J CLIN ENDOCR METAB, V95, P3347, DOI 10.1210/jc.2010-0288 | eng |
hcfmusp.relation.reference | Hameed EK, 2019, DIABETES METAB SYND, V13, P1241, DOI 10.1016/j.dsx.2019.01.039 | eng |
hcfmusp.relation.reference | Hudish LI, 2019, J CLIN INVEST, V129, P4001, DOI 10.1172/JCI129188 | eng |
hcfmusp.relation.reference | Klein S, 2007, DIABETES CARE, V30, P1647, DOI 10.2337/dc07-9921 | eng |
hcfmusp.relation.reference | Lopez AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035281 | eng |
hcfmusp.relation.reference | Low S, 2018, DIABETES RES CLIN PR, V143, P43, DOI 10.1016/j.diabres.2018.06.006 | eng |
hcfmusp.relation.reference | Malta Deborah Carvalho, 2017, Rev. bras. epidemiol., V20, P217, DOI 10.1590/1980-5497201700050018 | eng |
hcfmusp.relation.reference | Nick Todd G., 2007, V404, P273, DOI 10.1007/978-1-59745-530-5_14 | eng |
hcfmusp.relation.reference | Nusrianto R, 2019, DIABETES RES CLIN PR, V155, DOI 10.1016/j.diabres.2019.107798 | eng |
hcfmusp.relation.reference | Nusrianto R, 2019, DIABETES METAB SYND, V13, P1231, DOI 10.1016/j.dsx.2019.01.056 | eng |
hcfmusp.relation.reference | Padilha K, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1107-5 | eng |
hcfmusp.relation.reference | R Development Core Team, 2022, R LANG ENV STAT COMP | eng |
hcfmusp.relation.reference | Ramirez-Velez R, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112654 | eng |
hcfmusp.relation.reference | Sanchez-Garcia A, 2020, INT J ENDOCRINOL, V2020, DOI 10.1155/2020/4678526 | eng |
hcfmusp.relation.reference | Wu JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14251-w | eng |
hcfmusp.scopus.lastupdate | 2024-05-10 | |
relation.isAuthorOfPublication | a970d450-bcd4-4662-94d6-ad1c6d043b3c | |
relation.isAuthorOfPublication | 415ce7ca-65c1-4699-b6f4-19dae8b03849 | |
relation.isAuthorOfPublication.latestForDiscovery | a970d450-bcd4-4662-94d6-ad1c6d043b3c |
Arquivos
Pacote Original
1 - 1 de 1
Carregando...
- Nome:
- art_OLIVEIRA_Comparing_different_metabolic_indexes_to_predict_type_2_2022.PDF
- Tamanho:
- 475.27 KB
- Formato:
- Adobe Portable Document Format
- Descrição:
- publishedVersion (English)